MetaADEDB 2.0 @ LMMD
teduglutide
(CILIXQOJUNDIDU-ASQIGDHWSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(=O)O)[C@H](O)C)[C@H](CC)C)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1[nH]cnc1)N)CC(=O)O)CO)Cc1ccccc1)CO)CC(=O)O)CCC(=O)O)CCSC)CC(=O)N)CC(C)C)CC(=O)O)CC(=O)N)CC(C)C)C)C)CCCNC(=N)N)CC(=O)O)Cc1ccccc1)CC(=O)N)CC(C)C)CCC(=O)N
Molecular Formula:
C164H252N44O55S
Molecular Weight:
3752.080
Log P:
1.0163
Hydrogen Bond Acceptor:
98
Hydrogen Bond Donor:
55
TPSA:
1649.52
CAS Number(s):
197922-42-2
Synonym(s)
1.
teduglutide
2.
(Gly2)GLP-2
3.
Gly(2)-GLP-2
External Link(s)
MeSHC494910
PubChem Compound70683012
16139605
BindingDB50183895
ChEBI72305
CHEMBLCHEMBL2104987
DrugCentral4718
Therapeutic Target DatabaseD00RCI
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainFAERS: 149
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2NauseaFAERS: 148SIDER
US FAERS
3DehydrationFAERS: 104US FAERS
4VomitingFAERS: 97SIDER
US FAERS
5Weight decreasedFAERS: 86US FAERS
6Drug ineffectiveFAERS: 72US FAERS
7Inappropriate schedule of drug administrationFAERS: 67US FAERS
8Intestinal ObstructionFAERS: 67SIDER
US FAERS
9Drug dose omissionFAERS: 59US FAERS
10SepsisFAERS: 57US FAERS
11HeadacheFAERS: 53SIDER
US FAERS
12ObstructionFAERS: 53US FAERS
13Stoma complicationFAERS: 52US FAERS
14FatigueFAERS: 51US FAERS
15Device related infectionFAERS: 50US FAERS
16PneumoniaFAERS: 50US FAERS
17ConstipationFAERS: 45US FAERS
18FlatulenceFAERS: 42US FAERS
19Peripheral swellingFAERS: 42US FAERS
20MalaiseFAERS: 41US FAERS
21PainFAERS: 36US FAERS
22AstheniaFAERS: 33US FAERS
23InfectionFAERS: 31SIDER
US FAERS
24Inappropriate schedule of product administrationFAERS: 27US FAERS
25Abdominal discomfortFAERS: 26US FAERS
26Urinary tract infectionFAERS: 23US FAERS
27Gastrointestinal stoma complicationFAERS: 22SIDER
US FAERS
28Injection site bruisingFAERS: 22US FAERS
29Injection site painFAERS: 22SIDER
US FAERS
30Vascular device infectionFAERS: 22US FAERS
31Fluid overloadFAERS: 21US FAERS
32Injection site erythemaFAERS: 21SIDER
US FAERS
33PancreatitisFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34Back PainFAERS: 18US FAERS
35NasopharyngitisFAERS: 18US FAERS
36ThrombosisFAERS: 18US FAERS
37SwellingFAERS: 17SIDER
US FAERS
38ArthralgiaFAERS: 16SIDER
US FAERS
39Blood magnesium decreasedFAERS: 16US FAERS
40Blood potassium decreasedFAERS: 16US FAERS
41DizzinessFAERS: 16SIDER
US FAERS
42InfluenzaFAERS: 16SIDER
US FAERS
43NephrolithiasisFAERS: 15US FAERS
44Amylase increasedFAERS: 14US FAERS
45Chest PainFAERS: 14SIDER
US FAERS
46Complication associated with deviceFAERS: 14US FAERS
47Adverse eventFAERS: 13US FAERS
48ChillsFAERS: 13US FAERS
49Lipase increasedFAERS: 13US FAERS
50Joint swellingFAERS: 12US FAERS
51No adverse eventFAERS: 12US FAERS
52Unevaluable eventFAERS: 12US FAERS
53CholelithiasisFAERS: 11US FAERS
54HypotensionFAERS: 11US FAERS
55AlopeciaFAERS: 10US FAERS
56DyspepsiaFAERS: 10US FAERS
57HerniaFAERS: 10US FAERS
58HypersensitivityFAERS: 10US FAERS
59Injection Site ReactionFAERS: 10SIDER
US FAERS
60PruritusFAERS: 10US FAERS
61Device related sepsisFAERS: 8US FAERS
62Gastrointestinal stoma output increasedFAERS: 8US FAERS
63MalnutritionFAERS: 8SIDER
US FAERS
64Product dose omissionFAERS: 8US FAERS
65Stoma obstructionFAERS: 8US FAERS
66Therapy cessationFAERS: 8US FAERS
67Cerebrovascular accidentFAERS: 7US FAERS
68Clostridium difficile infectionFAERS: 7US FAERS
69Feeling abnormalFAERS: 7US FAERS
70Gastrointestinal obstructionFAERS: 7US FAERS
71Incorrect dose administeredFAERS: 7US FAERS
72Injection site massFAERS: 7US FAERS
73UrticariaFAERS: 7US FAERS
74ArthritisFAERS: 6US FAERS
75Blood creatine increasedFAERS: 6US FAERS
76Blood potassium increasedFAERS: 6US FAERS
77Bone painFAERS: 6US FAERS
78BronchitisFAERS: 6US FAERS
79CholecystitisFAERS: 6SIDER
US FAERS
80CystitisFAERS: 6US FAERS
81Product quality issueFAERS: 6US FAERS
82Septic ShockFAERS: 6US FAERS
83SinusitisFAERS: 6US FAERS
84Stoma site painFAERS: 6US FAERS
85AnxietyFAERS: 5SIDER
US FAERS
86Bowel movement irregularityFAERS: 5US FAERS
87CellulitisFAERS: 5US FAERS
88ColitisFAERS: 5US FAERS
89Depressed moodFAERS: 5US FAERS
90Electrolyte imbalanceFAERS: 5US FAERS
91ErythemaFAERS: 5US FAERS
92Injection site discomfortFAERS: 5US FAERS
93Musculoskeletal PainFAERS: 5US FAERS
94Myocardial InfarctionFAERS: 5US FAERS
95Needle issueFAERS: 5US FAERS
96Oropharyngeal painFAERS: 5US FAERS
97AscitesFAERS: 4US FAERS
98Blood albumin decreasedFAERS: 4US FAERS
99FlushingFAERS: 4SIDER
US FAERS
100HypophagiaFAERS: 4US FAERS
101InflammationFAERS: 4US FAERS
102Nonspecific reactionFAERS: 4US FAERS
103OsteoporosisFAERS: 4US FAERS
104Secretion dischargeFAERS: 4US FAERS
105Stoma site inflammationFAERS: 4US FAERS
106Stoma site reactionFAERS: 4US FAERS
107Abdominal AbscessFAERS: 3US FAERS
108Abdominal adhesionsFAERS: 3US FAERS
109Acute kidney injuryFAERS: 3US FAERS
110AgeusiaFAERS: 3US FAERS
111Ammonia increasedFAERS: 3US FAERS
112Anorectal discomfortFAERS: 3US FAERS
113Atrial FibrillationFAERS: 3US FAERS
114Blood creatinine increasedFAERS: 3US FAERS
115Blood glucose abnormalFAERS: 3US FAERS
116Chest discomfortFAERS: 3US FAERS
117Cholecystitis infectiveFAERS: 3US FAERS
118DeafnessFAERS: 3US FAERS
119Device difficult to useFAERS: 3US FAERS
120Device dislocationFAERS: 3US FAERS
121Electrolyte depletionFAERS: 3US FAERS
122Gastrointestinal motility disorderFAERS: 3US FAERS
123Gastrointestinal wall thickeningFAERS: 3US FAERS
124Injection site noduleFAERS: 3US FAERS
125LethargyFAERS: 3US FAERS
126MalabsorptionFAERS: 3US FAERS
127Night sweatsFAERS: 3SIDER
US FAERS
128OsteomyelitisFAERS: 3US FAERS
129Pancreatic CystFAERS: 3US FAERS
130Parenteral NutritionFAERS: 3US FAERS
131Pericardial effusionFAERS: 3US FAERS
132Post procedural complicationFAERS: 3US FAERS
133Procedural complicationFAERS: 3US FAERS
134Product use issueFAERS: 3US FAERS
135SomnolenceFAERS: 3US FAERS
136TremorFAERS: 3US FAERS
137Urine output increasedFAERS: 3US FAERS
138Abdominal tendernessFAERS: 2US FAERS
139AbscessFAERS: 2US FAERS
140AnosmiaFAERS: 2US FAERS
141AnuriaFAERS: 2US FAERS
142AphasiaFAERS: 2US FAERS
143AphoniaFAERS: 2US FAERS
144ArthropathyFAERS: 2US FAERS
145AsthmaFAERS: 2US FAERS
146BedriddenFAERS: 2US FAERS
147Biliary dilatationFAERS: 2US FAERS
148Blood alkaline phosphatase increasedFAERS: 2US FAERS
149Blood glucose decreasedFAERS: 2US FAERS
150Blood iron decreasedFAERS: 2US FAERS
151Blood phosphorus increasedFAERS: 2US FAERS
152Blood sodium decreasedFAERS: 2US FAERS
153Blood urine presentFAERS: 2US FAERS
154CystFAERS: 2US FAERS
155DementiaFAERS: 2US FAERS
156Device breakageFAERS: 2US FAERS
157Device leakageFAERS: 2US FAERS
158Disease ProgressionFAERS: 2US FAERS
159Dry skinFAERS: 2US FAERS
160DysarthriaFAERS: 2US FAERS
161DysphoniaFAERS: 2US FAERS
162DysplasiaFAERS: 2US FAERS
163DysuriaFAERS: 2US FAERS
164EpistaxisFAERS: 2US FAERS
165FibromyalgiaFAERS: 2US FAERS
166Gastrointestinal PainFAERS: 2SIDER
US FAERS
167Gastrointestinal infectionFAERS: 2US FAERS
168Gastrointestinal inflammationFAERS: 2US FAERS
169Gastrointestinal stoma output abnormalFAERS: 2US FAERS
170Gastrointestinal stoma output decreasedFAERS: 2US FAERS
171GoutFAERS: 2US FAERS
172Incorrect product storageFAERS: 2US FAERS
173Infected fistulaFAERS: 2US FAERS
174Infusion site reactionFAERS: 2US FAERS
175Injection site irritationFAERS: 2US FAERS
176Injection site pruritusFAERS: 2US FAERS
177Insurance issueFAERS: 2US FAERS
178Intestinal PerforationFAERS: 2US FAERS
179LymphadenopathyFAERS: 2US FAERS
180Memory impairmentFAERS: 2US FAERS
181Multiple allergiesFAERS: 2US FAERS
182MyalgiaFAERS: 2US FAERS
183Neck PainFAERS: 2US FAERS
184Pancreatic carcinomaFAERS: 2US FAERS
185Patient dissatisfaction with treatmentFAERS: 2US FAERS
186PharyngitisFAERS: 2US FAERS
187PneumothoraxFAERS: 2US FAERS
188Precancerous cells presentFAERS: 2US FAERS
189Pulmonary EmbolismFAERS: 2US FAERS
190Puncture site erythemaFAERS: 2US FAERS
191RegurgitationFAERS: 2US FAERS
192Renal Cell CarcinomaFAERS: 2US FAERS
193Renal massFAERS: 2US FAERS
194Skin PapillomaFAERS: 2US FAERS
195Skin WrinklingFAERS: 2US FAERS
196Stoma Site InfectionFAERS: 2US FAERS
197Stoma site dischargeFAERS: 2US FAERS
198Stoma site extravasationFAERS: 2US FAERS
199Stoma site hypergranulationFAERS: 2US FAERS
200StomatitisFAERS: 2US FAERS
201Therapeutic response unexpectedFAERS: 2US FAERS
202ThirstFAERS: 2US FAERS
203ThrombocytopeniaFAERS: 2US FAERS
204Wrong technique in product usage processFAERS: 2US FAERS
205Abdominal massFAERS: 1US FAERS
206Abdominal rigidityFAERS: 1US FAERS
207Absent bowel movementFAERS: 1US FAERS
208Accidental exposure to productFAERS: 1US FAERS
209Accidental overdoseFAERS: 1US FAERS
210Activities of daily living impairedFAERS: 1US FAERS
211AdenocarcinomaFAERS: 1US FAERS
212Administration site bruiseFAERS: 1US FAERS
213Alanine Aminotransferase IncreasedFAERS: 1US FAERS
214Albumin globulin ratio increasedFAERS: 1US FAERS
215AmnesiaFAERS: 1US FAERS
216AmyloidosisFAERS: 1US FAERS
217Anal FistulaFAERS: 1US FAERS
218Anal abscessFAERS: 1US FAERS
219AneurysmFAERS: 1US FAERS
220Angina PectorisFAERS: 1US FAERS
221Ankle FractureFAERS: 1US FAERS
222Aortic AneurysmFAERS: 1US FAERS
223Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
224Atypical pneumoniaFAERS: 1US FAERS
225Bacterial disease carrierFAERS: 1US FAERS
226Bile Duct StenosisFAERS: 1US FAERS
227Biliary cancer metastaticFAERS: 1US FAERS
228BlindnessFAERS: 1US FAERS
229Blood albumin abnormalFAERS: 1US FAERS
230Blood count abnormalFAERS: 1US FAERS
231Blood creatineFAERS: 1US FAERS
232Blood creatinine abnormalFAERS: 1US FAERS
233Blood creatinine decreasedFAERS: 1US FAERS
234Blood electrolytes abnormalFAERS: 1US FAERS
235Blood lactate dehydrogenase increasedFAERS: 1US FAERS
236Blood magnesium abnormalFAERS: 1US FAERS
237Blood magnesium increasedFAERS: 1US FAERS
238Blood potassium abnormalFAERS: 1US FAERS
239Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
240BronchospasmFAERS: 1US FAERS
241CalciphylaxisFAERS: 1US FAERS
242Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
243Cardiac ArrestFAERS: 1US FAERS
244CataractFAERS: 1US FAERS
245Catheter site extravasationFAERS: 1US FAERS
246Catheter site injuryFAERS: 1US FAERS
247Catheter site painFAERS: 1US FAERS
248Central nervous system lesionFAERS: 1US FAERS
249ChromaturiaFAERS: 1US FAERS
250Chronic diseaseFAERS: 1US FAERS
251ClubbingFAERS: 1US FAERS
252Cold sweatFAERS: 1US FAERS
253Compression fractureFAERS: 1US FAERS
254ConjunctivitisFAERS: 1US FAERS
255Conversion disorderFAERS: 1US FAERS
256Corneal dystrophyFAERS: 1US FAERS
257Cyst removalFAERS: 1US FAERS
258Deep Vein ThrombosisFAERS: 1US FAERS
259Dermal absorption increasedFAERS: 1US FAERS
260Device FailureFAERS: 1US FAERS
261Device occlusionFAERS: 1US FAERS
262Device use issueFAERS: 1US FAERS
263Dialysis related complicationFAERS: 1US FAERS
264DisorientationFAERS: 1US FAERS
265Disturbance in sexual arousalFAERS: 1US FAERS
266Drug DependenceFAERS: 1US FAERS
267Drug administration errorFAERS: 1US FAERS
268Dumping SyndromeFAERS: 1US FAERS
269DuodenitisFAERS: 1US FAERS
270Eating disorder symptomFAERS: 1US FAERS
271EmbolismFAERS: 1US FAERS
272Emergency CareFAERS: 1US FAERS
273Environmental ExposureFAERS: 1US FAERS
274Epigastric discomfortFAERS: 1US FAERS
275EpilepsyFAERS: 1US FAERS
276EructationFAERS: 1US FAERS
277Escherichia infectionFAERS: 1US FAERS
278Expired product administeredFAERS: 1US FAERS
279Extra dose administeredFAERS: 1US FAERS
280Eyelid margin crustingFAERS: 1US FAERS
281Febrile infectionFAERS: 1US FAERS
282Feeding tube complicationFAERS: 1US FAERS
283Feeling ColdFAERS: 1US FAERS
284Fluid imbalanceFAERS: 1US FAERS
285Frustration tolerance decreasedFAERS: 1US FAERS
286Gait inabilityFAERS: 1US FAERS
287GangreneFAERS: 1US FAERS
288Gastric DilatationFAERS: 1US FAERS
289Gastric mucosa erythemaFAERS: 1US FAERS
290Gastric ulcerFAERS: 1US FAERS
291GastritisFAERS: 1US FAERS
292GastroenteritisFAERS: 1US FAERS
293Gastrointestinal bacterial overgrowthFAERS: 1US FAERS
294Gastrointestinal carcinomaFAERS: 1US FAERS
295Gastrointestinal hypermotilityFAERS: 1US FAERS
296Gastrointestinal perforationFAERS: 1US FAERS
297Gender reassignment therapyFAERS: 1US FAERS
298General physical health deteriorationFAERS: 1US FAERS
299GlaucomaFAERS: 1US FAERS
300Graft infectionFAERS: 1US FAERS
301Hepatic EncephalopathyFAERS: 1US FAERS
302Hepatic InfectionFAERS: 1US FAERS
303Hepatitis CFAERS: 1US FAERS
304HepatitisFAERS: 1US FAERS
305Hernia painFAERS: 1US FAERS
306Hospice CareFAERS: 1US FAERS
307HydronephrosisFAERS: 1US FAERS
308HyperkeratosisFAERS: 1US FAERS
309HypersomniaFAERS: 1US FAERS
310HypothyroidismFAERS: 1US FAERS
311Immunosuppressant drug level increasedFAERS: 1US FAERS
312Inability to afford medicationFAERS: 1US FAERS
313Incision site complicationFAERS: 1US FAERS
314Infrequent bowel movementsFAERS: 1US FAERS
315Infusion site erythemaFAERS: 1US FAERS
316Infusion site painFAERS: 1US FAERS
317Injection related reactionFAERS: 1US FAERS
318Injection site drynessFAERS: 1US FAERS
319Injection site extravasationFAERS: 1US FAERS
320Injection site hypersensitivityFAERS: 1US FAERS
321Injection site infectionFAERS: 1US FAERS
322Injection site papuleFAERS: 1US FAERS
323Injection site scabFAERS: 1US FAERS
324Injection site scarFAERS: 1US FAERS
325Injection site urticariaFAERS: 1US FAERS
326Injection site warmthFAERS: 1US FAERS
327Intentional product misuseFAERS: 1US FAERS
328Intestinal infarctionFAERS: 1US FAERS
329Intestinal resectionFAERS: 1US FAERS
330Intestinal scarringFAERS: 1US FAERS
331Intestinal villi atrophyFAERS: 1US FAERS
332Iron deficiencyFAERS: 1US FAERS
333Large intestine perforationFAERS: 1US FAERS
334LeukopeniaFAERS: 1US FAERS
335Ligament ruptureFAERS: 1US FAERS
336Limb discomfortFAERS: 1US FAERS
337Limb injuryFAERS: 1US FAERS
338Limb massFAERS: 1US FAERS
339Limb operationFAERS: 1US FAERS
340Loss of personal independence in daily activitiesFAERS: 1US FAERS
341Lyme DiseaseFAERS: 1US FAERS
342Lymphocyte count decreasedFAERS: 1US FAERS
343Macular degenerationFAERS: 1US FAERS
344Magnesium DeficiencyFAERS: 1US FAERS
345MastectomyFAERS: 1US FAERS
346Medical device complicationFAERS: 1US FAERS
347Medication ErrorFAERS: 1US FAERS
348MegacolonFAERS: 1US FAERS
349Meniscus injuryFAERS: 1US FAERS
350MenorrhagiaFAERS: 1US FAERS
351Mental status changesFAERS: 1US FAERS
352Myasthenic SyndromeFAERS: 1US FAERS
353NoduleFAERS: 1US FAERS
354Nutritional condition abnormalFAERS: 1US FAERS
355OverdoseFAERS: 1US FAERS
356Pain of skinFAERS: 1US FAERS
357PallorFAERS: 1US FAERS
358PalpitationsFAERS: 1US FAERS
359Pancreatic duct dilatationFAERS: 1US FAERS
360Pelvic PainFAERS: 1US FAERS
361Pneumatosis intestinalisFAERS: 1US FAERS
362Portal HypertensionFAERS: 1US FAERS
363Post procedural discomfortFAERS: 1US FAERS
364Post procedural infectionFAERS: 1US FAERS
365Post-Traumatic Stress DisorderFAERS: 1US FAERS
366PrealbuminFAERS: 1US FAERS
367Precancerous skin lesionFAERS: 1US FAERS
368Prescribed underdoseFAERS: 1US FAERS
369ProctitisFAERS: 1US FAERS
370Product administration errorFAERS: 1US FAERS
371Product availability issueFAERS: 1US FAERS
372Product container issueFAERS: 1US FAERS
373Product label issueFAERS: 1US FAERS
374Product packaging issueFAERS: 1US FAERS
375Product packaging quantity issueFAERS: 1US FAERS
376Product physical consistency issueFAERS: 1US FAERS
377Progressive multiple sclerosisFAERS: 1US FAERS
378Protein DeficiencyFAERS: 1US FAERS
379Protein total decreasedFAERS: 1US FAERS
380Psychiatric evaluationFAERS: 1US FAERS
381Psychiatric symptomFAERS: 1US FAERS
382Pulmonary congestionFAERS: 1US FAERS
383Pupil dilation procedureFAERS: 1US FAERS
384Radiation injuryFAERS: 1US FAERS
385Rectal dischargeFAERS: 1US FAERS
386Rectal fissureFAERS: 1US FAERS
387Red man syndromeFAERS: 1US FAERS
388Rehabilitation therapyFAERS: 1US FAERS
389Renal painFAERS: 1US FAERS
390Respiratory FailureFAERS: 1US FAERS
391Restless Legs SyndromeFAERS: 1US FAERS
392Retinal DetachmentFAERS: 1US FAERS
393Rheumatoid ArthritisFAERS: 1US FAERS
394Rotator cuff syndromeFAERS: 1US FAERS
395SciaticaFAERS: 1US FAERS
396SeromaFAERS: 1US FAERS
397Skin UlcerFAERS: 1US FAERS
398Skin irritationFAERS: 1US FAERS
399Skin lesionFAERS: 1US FAERS
400Skin tightnessFAERS: 1US FAERS
401Slow speechFAERS: 1US FAERS
402SneezingFAERS: 1US FAERS
403Spinal cord infectionFAERS: 1US FAERS
404Squamous cell carcinoma of skinFAERS: 1US FAERS
405Squamous cell carcinomaFAERS: 1US FAERS
406StarvationFAERS: 1US FAERS
407Stoma site discomfortFAERS: 1US FAERS
408Stoma site erythemaFAERS: 1US FAERS
409Stoma site irritationFAERS: 1US FAERS
410Stomal herniaFAERS: 1US FAERS
411StressFAERS: 1US FAERS
412SyncopeFAERS: 1SIDER
US FAERS
413TachycardiaFAERS: 1US FAERS
414Therapeutic product effect decreasedFAERS: 1US FAERS
415Therapeutic product effect incompleteFAERS: 1US FAERS
416Therapy non-responderFAERS: 1US FAERS
417Thirst decreasedFAERS: 1US FAERS
418Throat irritationFAERS: 1US FAERS
419Thrombosis in deviceFAERS: 1US FAERS
420ThymomaFAERS: 1US FAERS
421TinnitusFAERS: 1US FAERS
422Toxicity to various agentsFAERS: 1US FAERS
423TracheomalaciaFAERS: 1US FAERS
424UlcerFAERS: 1US FAERS
425UnderweightFAERS: 1US FAERS
426Unresponsive to stimuliFAERS: 1US FAERS
427Upper-airway cough syndromeFAERS: 1US FAERS
428Urinary RetentionFAERS: 1US FAERS
429Urinary tract obstructionFAERS: 1US FAERS
430Vaginal lesionFAERS: 1US FAERS
431Visual ImpairmentFAERS: 1US FAERS
432Vocal Cord ParalysisFAERS: 1US FAERS
433Vulvovaginal swellingFAERS: 1US FAERS
434Wrong device usedFAERS: 1US FAERS
435Wrong doseFAERS: 1US FAERS
436CholestasisSIDER
437InfestationSIDER
438Musculoskeletal discomfortSIDER
439NeutropeniaCanada Vigilance: 1Canada Vigilance
440PericarditisCanada Vigilance: 1Canada Vigilance
441Renal ColicSIDER
442ShockSIDER
443VasculitisCanada Vigilance: 1Canada Vigilance
444nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.